Trial intelligence / Profile preview

Phase II dasatinib trial in chronic-phase chronic myeloid leukemia with late suboptimal molecular response after imatinib

2012-004259-36Phase 2Completed

Sponsor

Fundación PETHEMA

Start

Nov 2012

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1